Zura Bio (NASDAQ:ZURA – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.02), Yahoo Finance reports.
Zura Bio Stock Up 1.5 %
Shares of Zura Bio stock traded up $0.05 during trading on Wednesday, reaching $3.34. The company’s stock had a trading volume of 44,459 shares, compared to its average volume of 280,976. Zura Bio has a 12-month low of $2.00 and a 12-month high of $7.63. The business has a 50 day moving average price of $3.65 and a 200-day moving average price of $3.76.
Insider Activity at Zura Bio
In other Zura Bio news, Director Van Amstel Arnout Ploos purchased 80,000 shares of the firm’s stock in a transaction that occurred on Friday, May 17th. The shares were purchased at an average cost of $6.20 per share, for a total transaction of $496,000.00. Following the completion of the purchase, the director now directly owns 100,000 shares in the company, valued at $620,000. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 15.80% of the company’s stock.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on ZURA
Zura Bio Company Profile
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops Tibulizumab, an IgG-scFv bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes IL-17A and BAFF, which is in Phase 2 clinical trial development; ZB-168, a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL7 and thymic stromal lymphopoietin immune pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development.
Featured Stories
- Five stocks we like better than Zura Bio
- Learn Technical Analysis Skills to Master the Stock Market
- Microsoft Stock: Is Now The Time To Be Greedy?
- The Risks of Owning Bonds
- How to Invest in Mutual Funds
- What is a buyback in stocks? A comprehensive guide for investors
- Chipotle Mexican Grill: Take a Bite of This Smoking Hot Deal
Receive News & Ratings for Zura Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zura Bio and related companies with MarketBeat.com's FREE daily email newsletter.